A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome

Nerida L. Klupp*, Hosen Kiat, Alan Bensoussan, Genevieve Z. Steiner, Dennis H. Chang

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)
9 Downloads (Pure)

Fingerprint Dive into the research topics of 'A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences